For DuPont, a U.S.-headquartered multinational with a 200-year history, consistently being at the forefront of innovation in the advanced materials production industry is no small feat. The company has brought its innovative spirit and ability to continuously adapt and reinvent itself to all of its business endeavors, seeking solutions to solve the world’s most challenging…

As the climate crisis continues to impact people and communities across the globe, governments, civil society, and private industry are coming together to begin counteracting the worst effects of this phenomenon, as well as to bring countries closer to their future goals of achieving net-zero carbon emissions. To aid in this collective response, Taiwan’s semiconductor…

Last May, research-based global biopharmaceutical firm AbbVie finalized a transformative acquisition of Allergan, an Ireland-headquartered healthcare solutions provider. The transaction made AbbVie, a relatively young spinoff of the long-established Abbott Laboratories, the fifth largest biopharmaceutical company in the world. It further diversified the company’s robust product portfolio, expanded and strengthened its already robust R&D pipeline,…

The company hopes to benefit citizens and shed new light on the treatment of cancer. Pfizer Taiwan and the National Health Research Institutes (NHRI), along with two other partnering companies, recently signed a precision medicine cooperation alliance agreement, officially launching a joint initiative to develop precision cancer treatments in Taiwan. The agreement commits all parties…

Finding effective solutions to the world’s health issues requires novel, holistic approaches and collaborative ingenuity. Healthcare companies must therefore increasingly shift their focus to the research and development of medical technologies, biopharmaceuticals, and innovative therapies to treat conditions and diseases that are difficult or nearly impossible to tackle using traditional medicines. Such a reality is…